Mary Ann Gray is a director of BioAtla Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RAPT Therapeutics, Inc.
1 Apr 24
4
Compass Therapeutics, Inc.
14 Feb 24
4
BioAtla, Inc.
3 Jan 24
4
PALISADE BIO, INC.
24 Nov 23
4
BioAtla, Inc.
3 Oct 23
4
BioAtla, Inc.
5 Jul 23
4
BioAtla, Inc.
15 Jun 23
4
PALISADE BIO, INC.
13 Jun 23
4
Keros Therapeutics, Inc.
8 Jun 23
4
RAPT Therapeutics, Inc.
25 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Mar 24 | RAPT RAPT Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.58 | 8,574 | 64.99 k | 8,574 |
31 Dec 23 | BCAB BioAtla | Common Stock | Grant | Acquire A | No | No | 0 | 5,995 | 0.00 | 37,397 |
21 Nov 23 | PALI Palisade Bio | Common Stock | Grant | Acquire A | No | No | 0.59 | 6,880 | 4.06 k | 6,880 |
21 Nov 23 | PALI Palisade Bio | Common Stock | Grant | Acquire A | No | No | 0 | 5,820 | 0.00 | 5,820 |
30 Sep 23 | BCAB BioAtla | Common Stock | Grant | Acquire A | No | No | 0 | 8,676 | 0.00 | 31,402 |
14 Jun 23 | BCAB BioAtla | Stock Option Common Stock | Grant | Acquire A | No | No | 3.55 | 50,000 | 177.50 k | 50,000 |